Donepezil Hydrochloride is a noncompetitive acetylcholinesterase inhibitor (IC50 = 11.6 nM. It is known that Donepezil Hydrochloride is a useful tool in the study of Alzheimer's disease. Studies indicate that Donepezil Hydrochloride protects the brain against diisopropylfluorophosphate-induced effects. Studies indicate that Donepezil Hydrochloride selectively inhibits acetylcholinesterase, whereas it has little effect on butyrylcholinesterase. Alternate studies suggest that Donepezil Hydrochloride increases the concentration of extracellular acetylcholine.
1. Shintani, E.Y., et al. 1997. Am J Health Syst Pharm. 54: 2805-2810. PMID: 9428950
2. Bryson, H.M. and Benfield, P. 1997. Drugs Aging. 10: 234-240. PMID: 9108896
See how others have used Donepezil hydrochloride (CAS 120011-70-3). Click on the entry to view the PubMed entry .
PMID: # 27855959 Liew, KF.|Hanapi, NA.|Chan, KL.|Yusof, SR.|Lee, CY.| et al. 2017. J Pharm Sci. 106: 502-510.
PMID: # 30466001 Biomed Pharmacother. 118-128.
PMID: # 31866203 Dev. Cell.
PMID: # 25455147 J Nat Prod. 2716-9.
PMID: # 32831882 Evid Based Complement Alternat Med. 9058135.